A diagnostic challenge-First case of chronic lymphatic leukemia-associated necrotizing sweet syndrome

Eur J Haematol. 2024 Apr;112(4):650-653. doi: 10.1111/ejh.14153. Epub 2023 Dec 17.

Abstract

Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare disorder typically characterized by the clinical triad including a sudden onset of fever, painful skin lesions, and neutrophilia. The histopathological findings are a dense neutrophilic infiltrate and oedema of the dermis and epidermis without evidence of a vasculitis. Besides treatment of the underlying cause, sweet syndrome is typically treated with high-dose corticosteroids leading to a relapse-free response in 70% of patients. However, if left unrecognized or untreated, the condition may lead to serious complications. Here, we report on the case of a 38-year-old patient in whom, under the assumption of the presence of necrotizing fasciitis, exarticulation of the right arm was performed. In the absence of pathogen detection and insufficient response to anti-infective therapies, the diagnosis of a sweet syndrome was assumed and, later, confirmed by an excellent response to high-dose administration of systematic glucocorticoids. The case emphasizes the need to be aware of this rare syndrome, which can be easily misdiagnosed due to its close resemblance to infection and stresses the need of further research to define distinct diagnostic tools.

Keywords: CLL; Sweet Syndrome; necrotizing Sweet Syndrome; necrotizing fasciitis.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Fever / diagnosis
  • Fever / etiology
  • Glucocorticoids
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / complications
  • Sweet Syndrome* / diagnosis
  • Sweet Syndrome* / drug therapy
  • Sweet Syndrome* / etiology

Substances

  • Adrenal Cortex Hormones
  • Glucocorticoids